Clinical trial
Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients With Incurable Solid Tumors: A Phase I Study
NCT00006126 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Allogeneic Peripheral Blood Progenitor Cell Transplantation in Patients With Incurable Solid Tumors: A Phase I Study
- Lead sponsor
- Northwestern University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- September 30, 1999
- Completion date
- April 30, 2001
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, kidney cancer, lung cancer, melanoma (skin), testicular germ cell tumor